The recognition of pseudomembranous colitis as a clinical entity.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001344:Autopsy; D001466:Barium Sulfate; D001706:Biopsy; D001798:Blood Proteins / Q000032:analysis; D003092:Colitis / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis* / Q000382:microbiology / Q000473:pathology; D003106:Colon / Q000473:pathology; D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008034:Lincomycin / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010808:Physical Examination; D012007:Rectum / Q000473:pathology; D012812:Sigmoidoscopy
D000900:Anti-Bacterial Agents; D001798:Blood Proteins; D001466:Barium Sulfate; D008034:Lincomycin